Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ResMed Tops Expectations but Falls Anyway


ResMed Tops Expectations but Falls Anyway

Medical-device maker ResMed (NYSE: RMD) reported its fiscal fourth-quarter results after the market closed on Tuesday, Aug. 1. The continuous positive airway pressure (CPAP) pioneer reported modest top-line growth when compared with last quarter, but margin improvements help drive better-than-expected results on the bottom line. 

Let's take a closer look at the company's results to get a better sense of how it fared during the period.

Image source: Getty Images.

Continue reading


Source: Fool.com

Resmed Inc. Stock

€189.90
3.540%
A very strong showing by Resmed Inc. today, with an increase of €6.50 (3.540%) compared to yesterday's price.
Resmed Inc. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
As a result the target price of 258 € shows a positive potential of 35.86% compared to the current price of 189.9 € for Resmed Inc..
Like: 0
RMD
Share

Comments